Literature DB >> 414366

Hormones and the pathophysiology of fibrocystic mastopathy.

R C Golinger.   

Abstract

There is some reason to believe that common benign diseases of the breast are in great part caused by abnormalities of the hormonal milieu in which the breasts exist. Relative hyperestrinism by itself may cause mammary dysplasia, but it is likely that etiologic contributions are required from genetic factors within the cells of the mammary gland, from abnormalities of pituitary mammotropic hormone activity and from surplus or deficit of other circulating nongonadal factors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 414366

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

1.  Abandoning fibrocystic disease of the breast: timely end of an era.

Authors:  J E Devitt
Journal:  CMAJ       Date:  1986-02-01       Impact factor: 8.262

2.  How to do it . . . Appear on television.

Authors:  K Sabbagh
Journal:  Br Med J       Date:  1978-10-21

3.  The use of bromocriptine in the management of non-puerperal mastitis.

Authors:  F Peters; M Hilgarth; M Breckwoldt
Journal:  Arch Gynecol       Date:  1982

4.  The correlation of histologic changes in the human breast with the menstrual cycle.

Authors:  P M Vogel; N G Georgiade; B F Fetter; F S Vogel; K S McCarty
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

5.  Nimesulide in the treatment of mastalgia.

Authors:  G Gabbrielli; P Binazzi; I Scaricabarozzi; G B Massi
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 6.  Nonendocrine theories of the etiology of benign breast disease.

Authors:  J P Minton; H Abou-Issa
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

7.  Treatment of severe cyclical mastalgia.

Authors:  A C Montgomery; B V Palmer; S Biswas; J C Monteiro
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 18.000

8.  Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.

Authors:  Yaqin Chen; Anthony Bekhash; Albert J Kovatich; Jeffrey A Hooke; Jianfang Liu; Leonid Kvecher; J Leigh Fantacone-Campbell; Edith P Mitchell; Hallgeir Rui; Richard J Mural; Craig D Shriver; Hai Hu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.